Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
November 1996

Cutaneous Carcinoma During Long-term Hydroxyurea Therapy: A Report of 5 Cases

Author Affiliations



Arch Dermatol. 1996;132(11):1395-1397. doi:10.1001/archderm.1996.03890350139035

Five cases of cutaneous carcinoma occurred during long-term hydroxyurea therapy. Herein the responsibility of this drug in the onset of the tumors will be discussed.

Report of Cases.  Five white patients with skin photo-type II or III, were living in France and had no history of cutaneous carcinoma before treatment (Table 1 and Table 2). The patients received hydroxyurea for 2 to 10 years (mean, 6½ years), with cumulative doses between 650 and 3600 g. The patients' mean age was 71 years. Cutaneous carcinomas are actually frequent in the eighth decade of life; nevertheless, we suspect hydroxyurea of having a cutaneous carcinogenic effect in these patients, although it is now impossible to prove this. Indeed, our attention was drawn because of the sudden onset of tumors over a few weeks in patient 1, the large number and size of tumors in patients 2 and 5, and the remarkable absence of

First Page Preview View Large
First page PDF preview
First page PDF preview